Concepedia

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi’s sarcoma patients treated with pegylated liposomal doxorubicin

Gerald J. Berry, Margaret E. Billingham, Edwin L. Alderman, PG Richardson, Frank M. Torti, B L Lum, A. J. Patek, Francisco J. Plaza Martín

Annals of Oncology · 1998 · 240 citations · 20 references

DOIFull text

Open access

Concepts

References

20

A clinicopathologic analysis of adriamycin cardiotoxicity

Edward A. Lefrak, Jan Piťha, Sidney Rosenheim et al. · Cancer · 1973 · 1.6K citations

, , +16

Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion

Sewa S. Legha, Robert S. Benjamin, Bruce R. MacKay et al. · Annals of Internal Medicine · 1982 · 769 citations

, , +13

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

Franco M. Muggia, John D. Hainsworth, Susan Jeffers et al. · Journal of Clinical Oncology · 1997 · 657 citations

, , +17

Anthracycline cardiomyopathy monitored by morphologic changes.

Billingham Me, Mason Jw, Bristow Mr et al. · PubMed · 1978 · 593 citations

, , +17

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.

Parkash S. Gill, J Wernz, David T. Scadden et al. · Journal of Clinical Oncology · 1996 · 439 citations

, , +10